ZVRA – zevra therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Zevra Ties NPC Testing Push To Valuation Gap And New CFO [Yahoo! Finance]
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements [Yahoo! Finance]
Zevra Therapeutics (ZVRA) is now covered by BTIG Research. They set a "buy" rating and a $23.00 price target on the stock.
Form PRE 14A ZEVRA THERAPEUTICS, INC. For: Apr 06
Form SCHEDULE 13G/A ZEVRA THERAPEUTICS, INC. Filed by: VANGUARD GROUP INC
Form 4 ZEVRA THERAPEUTICS, INC. For: Mar 24 Filed by: Bode John B
Form 4 ZEVRA THERAPEUTICS, INC. For: Mar 18 Filed by: Renz Justin A
Form 3 ZEVRA THERAPEUTICS, INC. For: Mar 18 Filed by: Renz Justin A
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.